Nath Bio-Genes

{
  "main_header": {
    "sid": 628630,
    "name": "Nath Bio-Genes",
    "stock_name": "Nath Bio-Genes",
    "full_name": "Nath Bio-Genes (India) Ltd",
    "name_url": "stocks-analysis/nath-bio-genes",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "171.15",
    "chg": -3.3,
    "chgp": "-1.89%",
    "dir": -1,
    "prev_price": "174.45",
    "mcapval": "332.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 537291,
    "symbol": "NATHBIOGEN",
    "ind_name": "Other Agricultural Products",
    "ind_code": 107,
    "indexname": "India SENSEX",
    "isin": "INE448G01010",
    "curr_date": "May 08",
    "curr_time": "",
    "bse_nse_vol": "29.67 k",
    "exc_status": "Active",
    "traded_date": "May 08, 2026",
    "traded_date_str": "2026 05 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/nath-bio-genes-628630-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Nath Bio-Genes Falls 9.61% Amid Profit Wipeout and Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nath-bio-genes-falls-961-amid-profit-wipeout-and-mixed-financial-signals-3983506",
        "imagepath": "",
        "date": "2026-05-09 16:08:08",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>May 5:</strong> Profit wipeout amid tax anomaly raises red flags</p>\n                    <p><strong>May 6:</strong> Flat quarterly performance reported with mixed financial trends</p>\n                    <p><strong>May 8:</strong> Week closes at Rs.171.15, down 9.61%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.189.35</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.171.15</div><div class=\"stat-change negative\">-9.61%</div></div>\n                    <div class=\"stat-item\"><div cl..."
      },
      {
        "title": "Nath Bio-Genes Reports Flat Quarterly Performance Amid Mixed Financial Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nath-bio-genes-reports-flat-quarterly-performance-amid-mixed-financial-trends-3977731",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NathBioGenesInd_fintrenddot_3977731.png",
        "date": "2026-05-06 11:00:16",
        "description": "Nath Bio-Genes (India) Ltd has reported a flat financial performance for the quarter ended March 2026, signalling a stabilisation after a period of decline. While net sales have shown robust growth, profitability metrics and earnings per share continue to face headwinds, reflecting a complex financial landscape for this micro-cap player in the Other Agricultural Products sector."
      },
      {
        "title": "Are Nath Bio-Genes (India) Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-nath-bio-genes-india-ltd-latest-results-good-or-bad-3976442",
        "imagepath": "",
        "date": "2026-05-05 19:16:48",
        "description": "Nath Bio-Genes (India) Ltd reported its financial results for Q4 FY26, revealing a complex operational landscape. The company experienced a net profit of -₹0.01 crores, reflecting a significant decline of 100.68% year-on-year. This loss was primarily driven by an unusually high effective tax rate of 100.40%, which exceeded the pre-tax profit of ₹2.49 crores, effectively nullifying earnings for the quarter. \n\nIn terms of revenue, Nath Bio-Genes recorded net sales of ₹51.59 crores, which represents a slight decline of 0.73% compared to the same quarter last year. However, this figure marked a more pronounced quarter-on-quarter decrease of 21.79% from ₹65.96 crores in Q3 FY26, indicating volatility in sales performance. The operating margin improved to 8.68%, a notable increase from 0.79% in Q4 FY25, suggesting some operational efficiency gains despite the overall profit loss.\n\nThe company’s financial performa..."
      },
      {
        "title": "Nath Bio-Genes Q4 FY26: Profit Wipeout Amid Tax Anomaly Raises Red Flags",
        "link": "https://www.marketsmojo.com/news/result-analysis/nath-bio-genes-q4-fy26-profit-wipeout-amid-tax-anomaly-raises-red-flags-3975973",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/NathBioGenesInd_quaterlyResult_3975973.png",
        "date": "2026-05-05 09:49:12",
        "description": "Nath Bio-Genes (India) Ltd., a micro-cap agricultural products company with a market capitalisation of ₹330.86 crores, reported a shocking loss of ₹0.01 crores for Q4 FY26, marking a complete reversal from the ₹0.94 crores profit posted in Q4 FY25. The stock plunged 7.87% on May 5, 2026, closing at ₹174.45, as investors reacted to an extraordinary tax charge that exceeded the company's pre-tax profit—a rare accounting anomaly that signals potential earnings quality concerns."
      },
      {
        "title": "Nath Bio-Genes (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-india-ltd-is-rated-sell-3969968",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NathBioGenesInd_mojoScore_3969968.png",
        "date": "2026-04-30 10:10:38",
        "description": "Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Nath Bio-Genes (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-india-ltd-is-rated-sell-3952845",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NathBioGenesInd_mojoScore_3952845.png",
        "date": "2026-04-19 10:10:37",
        "description": "Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "A 10.53% Single-Day Surge Takes Nath Bio-Genes (India) Ltd to Its Upper Circuit Limit of Rs 183.52",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/nath-bio-genes-surges-to-upper-circuit-on-robust-buying-momentum-3944974",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NathBioGenesInd_stocks_hitting_upper_circuit_3944974.png",
        "date": "2026-04-13 15:00:08",
        "description": "At Rs 183.52, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Nath Bio-Genes (India) Ltd locked at its upper circuit of 10.53% on 13 Apr 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Nath Bio-Genes (India) Ltd Upgraded to Sell on Technical Improvement Despite Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-india-ltd-upgraded-to-sell-on-technical-improvement-despite-weak-fundamentals-3936587",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NathBioGenesInd_mojoScore_3936587.png",
        "date": "2026-04-08 08:17:53",
        "description": "Nath Bio-Genes (India) Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift in its technical outlook despite persistent fundamental challenges. The micro-cap agricultural products company’s recent performance and valuation metrics have prompted a reassessment across quality, valuation, financial trend, and technical parameters, signalling cautious optimism for investors."
      },
      {
        "title": "Nath Bio-Genes (India) Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/nath-bio-genes-india-ltd-is-rated-strong-sell-3932876",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/NathBioGenesInd_mojoScore_3932876.png",
        "date": "2026-04-04 10:10:35",
        "description": "Nath Bio-Genes (India) Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 04 April 2026, providing investors with the latest insights into the company’s performance and outlook."
      }
    ],
    "total": 164,
    "sid": "628630",
    "stock_news_url": "https://www.marketsmojo.com/news/nath-bio-genes-india-628630"
  },
  "announcements": [
    {
      "caption": "Outcome Of Board Meeting",
      "datetime": "04-May-2026",
      "details": "Audited Financial Results as on 31st March 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "04-May-2026",
      "details": "Investor Presentation on Financial Results as on 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
      "datetime": "04-May-2026",
      "details": "Outcome of Board Meeting held on 04th May 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Nath Bio-Genes (India) Ltd has declared <strong>20%</strong> dividend, ex-date: 14 Aug 25",
          "dt": "2025-08-14",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Nath Bio-Genes Falls 9.61% Amid Profit Wipeout and Mixed Financial Signals

2026-05-09 16:08:08

Key Events This Week

May 5: Profit wipeout amid tax anomaly raises red flags

May 6: Flat quarterly performance reported with mixed financial trends

May 8: Week closes at Rs.171.15, down 9.61%

Week Open

Rs.189.35

Week Close

Rs.171.15

-9.61%

Read full news article

Nath Bio-Genes Reports Flat Quarterly Performance Amid Mixed Financial Trends

2026-05-06 11:00:16

Nath Bio-Genes (India) Ltd has reported a flat financial performance for the quarter ended March 2026, signalling a stabilisation after a period of decline. While net sales have shown robust growth, profitability metrics and earnings per share continue to face headwinds, reflecting a complex financial landscape for this micro-cap player in the Other Agricultural Products sector.

Read full news article

Are Nath Bio-Genes (India) Ltd latest results good or bad?

2026-05-05 19:16:48

Nath Bio-Genes (India) Ltd reported its financial results for Q4 FY26, revealing a complex operational landscape. The company experienced a net profit of -₹0.01 crores, reflecting a significant decline of 100.68% year-on-year. This loss was primarily driven by an unusually high effective tax rate of 100.40%, which exceeded the pre-tax profit of ₹2.49 crores, effectively nullifying earnings for the quarter. In terms of revenue, Nath Bio-Genes recorded net sales of ₹51.59 crores, which represents a slight decline of 0.73% compared to the same quarter last year. However, this figure marked a more pronounced quarter-on-quarter decrease of 21.79% from ₹65.96 crores in Q3 FY26, indicating volatility in sales performance. The operating margin improved to 8.68%, a notable increase from 0.79% in Q4 FY25, suggesting some operational efficiency gains despite the overall profit loss. The company’s financial performa...

Read full news article

Nath Bio-Genes Q4 FY26: Profit Wipeout Amid Tax Anomaly Raises Red Flags

2026-05-05 09:49:12

Nath Bio-Genes (India) Ltd., a micro-cap agricultural products company with a market capitalisation of ₹330.86 crores, reported a shocking loss of ₹0.01 crores for Q4 FY26, marking a complete reversal from the ₹0.94 crores profit posted in Q4 FY25. The stock plunged 7.87% on May 5, 2026, closing at ₹174.45, as investors reacted to an extraordinary tax charge that exceeded the company's pre-tax profit—a rare accounting anomaly that signals potential earnings quality concerns.

Read full news article

Nath Bio-Genes (India) Ltd is Rated Sell

2026-04-30 10:10:38

Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 April 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Nath Bio-Genes (India) Ltd is Rated Sell

2026-04-19 10:10:37

Nath Bio-Genes (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

A 10.53% Single-Day Surge Takes Nath Bio-Genes (India) Ltd to Its Upper Circuit Limit of Rs 183.52

2026-04-13 15:00:08

At Rs 183.52, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Nath Bio-Genes (India) Ltd locked at its upper circuit of 10.53% on 13 Apr 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Nath Bio-Genes (India) Ltd Upgraded to Sell on Technical Improvement Despite Weak Fundamentals

2026-04-08 08:17:53

Nath Bio-Genes (India) Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift in its technical outlook despite persistent fundamental challenges. The micro-cap agricultural products company’s recent performance and valuation metrics have prompted a reassessment across quality, valuation, financial trend, and technical parameters, signalling cautious optimism for investors.

Read full news article

Nath Bio-Genes (India) Ltd is Rated Strong Sell

2026-04-04 10:10:35

Nath Bio-Genes (India) Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 04 April 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

View All News